| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/11/2010 | US20100285452 Molecular Markers for the Diagnosis and Treatment of Tumors |
| 11/11/2010 | US20100285451 Detection of sub-cellular compartment localization of a molecule using a reduced affinity enzyme complementation reporter system |
| 11/11/2010 | US20100285450 Compositions and assays to detect influenza virus a and b nucleic acids |
| 11/11/2010 | US20100285449 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 11/11/2010 | US20100285448 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 11/11/2010 | US20100285447 Methods for Antimicrobial Resistance Determination |
| 11/11/2010 | US20100285446 Methods for Detecting Metabolic States by Laser Ablation Electrospray Ionization Mass Spectrometry |
| 11/11/2010 | US20100285445 Chimeric construct of mungbean yellow mosaic india virus (mymiv) and its uses thereof |
| 11/11/2010 | US20100285444 HBV precore protein capable of forming particles |
| 11/11/2010 | US20100285443 Diagnostic Methods for Diseases Caused by a HPV Infection Comprising Determining the Methylation Status of the HPV Genome |
| 11/11/2010 | US20100285152 Composition for improving liver metabolism and diagnostic method |
| 11/11/2010 | US20100285109 Truncated secretory aspartyl proteinase 2 |
| 11/11/2010 | US20100285082 Integrated Biosensor and Simulation System for Diagnosis and Therapy |
| 11/11/2010 | US20100285073 a micro-rna family that modulates fibrosis and uses thereof |
| 11/11/2010 | US20100285070 Polynucleotides of haemophilus parasuis and its use |
| 11/11/2010 | US20100285058 Dna vaccine for treating or preventing cervical cancer comprising a gene encoding hpv protein |
| 11/11/2010 | US20100285049 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 11/11/2010 | US20100285047 Therapeutics and diagnostics for group a streptococci |
| 11/11/2010 | US20100285045 Novel Neurotrophic Factor Protein and Uses Thereof |
| 11/11/2010 | US20100285026 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 11/11/2010 | US20100285023 Detecting cyp24 expression level as a marker for predisposition to cancer |
| 11/11/2010 | US20100285017 Matriptase protein and uses thereof |
| 11/11/2010 | US20100285001 Method and Compositions Related to Synergistic Responses to Oncogenic Mutations |
| 11/11/2010 | US20100284999 Characterization of the cbir1 antigenic response for diagnosis and treatment of crohn's disease |
| 11/11/2010 | US20100284991 Methods for the Treatment and Diagnosis of Bone Mineral Density Related Diseases |
| 11/11/2010 | US20100284989 15-pgdh in colon cancer |
| 11/11/2010 | US20100284973 Use of a L. Casei Strain For the Preparation of a Composition for Inhibiting Mast Cell Activation |
| 11/11/2010 | US20100284968 Use of PS20/WFDC1 and Interferons to Diagnose, Monitor and Treat Viral Diseases |
| 11/11/2010 | US20100284966 Methods and Compositions for Managing Resistance of Hepatitis C Virus to Immunosuppressant |
| 11/11/2010 | US20100284935 Markers and diagnostic methods for metastasis |
| 11/11/2010 | US20100284933 Biomarkers of Multiple Sclerosis |
| 11/11/2010 | US20100284918 Protein |
| 11/11/2010 | US20100284917 Compounds and markers for surface-enhanced raman scattering |
| 11/11/2010 | US20100284916 Antibodies Against Human Cytomegalovirus (HCMV) |
| 11/11/2010 | US20100284915 Genes associated with chemotherapy response and uses thereof |
| 11/11/2010 | US20100284910 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers |
| 11/11/2010 | US20100284905 Methods and Agents for Inhibiting Tumor Growth by Targeting the SSDNA Replication Intermediate of Tumor Stem Cells |
| 11/11/2010 | CA2765632A1 Smart packaging for detecting microorganisms |
| 11/11/2010 | CA2761614A1 Human fg01 gene and its applications |
| 11/11/2010 | CA2761411A1 Microrna expression profiling and targeting in chronic obstructive pulmonary disease (copd) lung tissue and methods of use thereof |
| 11/11/2010 | CA2761406A1 Methods of analyzing peptide mixtures |
| 11/11/2010 | CA2761194A1 Generic assays for detection of influenza viruses |
| 11/11/2010 | CA2760943A1 Shoc2 mutations causing noonan-like syndrome with loose anagen hair |
| 11/11/2010 | CA2760941A1 System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function |
| 11/11/2010 | CA2760922A1 Rapid sterility microassay |
| 11/11/2010 | CA2760876A1 Novel sugar transporters |
| 11/11/2010 | CA2760814A1 Hepatocellular carcinoma |
| 11/11/2010 | CA2760159A1 Methods of treating bacterial infections using oritavancin |
| 11/11/2010 | CA2760155A1 Real-time sequencing methods and systems |
| 11/11/2010 | CA2759992A1 Detection of multiple nucleic acid sequences in a reaction cartridge |
| 11/11/2010 | CA2759851A1 Genetic variants contributing to risk of prostate cancer |
| 11/11/2010 | CA2749870A1 Genetic severity markers in multiple sclerosis |
| 11/10/2010 | EP2249163A2 Method of pretreating sample for measurement of glycated amine |
| 11/10/2010 | EP2248915A1 Detection of multiple nucleic acid sequences in a reaction cartridge |
| 11/10/2010 | EP2248914A1 The use of class IIB restriction endonucleases in 2nd generation sequencing applications |
| 11/10/2010 | EP2248913A1 Epigenetic marker for the identification of natural killer cells |
| 11/10/2010 | EP2248912A1 High sensitivity assays for pathogen detection using metal-enhanced fluorescence |
| 11/10/2010 | EP2248911A1 Methods and kits for analyzing polynucleotide sequences |
| 11/10/2010 | EP2248910A1 Epitope synchronization in antigen presenting cells |
| 11/10/2010 | EP2248909A1 Compositions for assaying glycoprotein |
| 11/10/2010 | EP2248900A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 11/10/2010 | EP2248898A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 11/10/2010 | EP2248897A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 11/10/2010 | EP2248896A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 11/10/2010 | EP2248894A1 Novel dna fragment and use thereof |
| 11/10/2010 | EP2248822A2 Meningococcus adhesins |
| 11/10/2010 | EP2248821A1 Substrate for assaying -glucan and/or endotoxin and assay method |
| 11/10/2010 | EP2248820A1 Universal supports for oligonucleotide synthesis |
| 11/10/2010 | EP2247758A2 Oil emulsions and methods for manufacture and use thereof |
| 11/10/2010 | EP2247757A2 Biomarkers for sensitivity to anti-igf1r therapy |
| 11/10/2010 | EP2247756A2 Method and kit for the detection of genes associated with pik3ca mutation and involved in pi3k/akt pathway activation in the er-positive and her2-positive subtypes with clinical implications |
| 11/10/2010 | EP2247755A1 Susceptibility variants for lung cancer |
| 11/10/2010 | EP2247754A1 Colon cancer associated transcript 1 (ccat1) as a cancer marker |
| 11/10/2010 | EP2247753A1 Urine transport medium |
| 11/10/2010 | EP2247752A1 Prediction and diagnosis of canine degenerative myelopathy |
| 11/10/2010 | EP2247751A2 Disease resistant pepper plants |
| 11/10/2010 | EP2247750A1 Methods and compositions relating to carcinoma stem cells |
| 11/10/2010 | EP2247749A1 Covalently linked thermostable kinase for decontamination process validation |
| 11/10/2010 | EP2247748A2 Alpha-synuclein kinase |
| 11/10/2010 | EP2247747A2 Cell culture article and screening |
| 11/10/2010 | EP2247741A2 Paired-end reads in sequencing by synthesis |
| 11/10/2010 | EP2247734A2 New brassica ogura restorer lines with shortened raphanus fragment (srf) |
| 11/10/2010 | EP2247731A2 Aptamer inhibitors of osteopontin and methods of use thereof |
| 11/10/2010 | EP2247728A1 Selection of rna-aptamers as anti-malaria agents |
| 11/10/2010 | EP2247727A2 Method for archiving and clonal expansion |
| 11/10/2010 | EP2247612A1 Siva 3, its preparation and use |
| 11/10/2010 | EP1947195B1 Method for the in vitro detection of a predisposition to the development of alterations in ovarian function |
| 11/10/2010 | EP1704160B1 Methods and compositions for identifying rna-binding proteins |
| 11/10/2010 | EP1697545B1 Multiplex nucleic acid analysis of HPV genotypes |
| 11/10/2010 | EP1687634B1 Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules |
| 11/10/2010 | EP1619961B1 Method for the in situ production of an emulsifier in a foodstuff |
| 11/10/2010 | EP1616183B1 Methods of detecting neurological disorders |
| 11/10/2010 | EP1546374B1 Method for detecting transferase enzymatic activity |
| 11/10/2010 | EP1362125B1 METHOD FOR IDENTIFYING of BIOLOGICALLY ACTIVE STRUCTURES OF MICROBIAL PATHOGENS |
| 11/10/2010 | EP1265915B1 Novel compounds |
| 11/10/2010 | EP1015477B1 32 Human secreted proteins |
| 11/10/2010 | CN1934447B Process for producing biochip |
| 11/10/2010 | CN1925741B Animal genotyping method |
| 11/10/2010 | CN1904048B Zebra fish egg yolk protein origin 1 gene regulating and controlling sequence |
| 11/10/2010 | CN1892221B Method for stabilizing clinical diagnostic reagent comprising glucose 6-phosphate dehydrogenase (G6PDH) and G6PDH |